Valeant Pharmaceuticals Announces Second Quarter Results Conference Call Date And Details
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Valeant Pharma (VRX) Brodalumab Briefing Docs Posted; Concerns Linger
July 15, 2016 8:10 AM EDTBriefing docs for Valeant's (NYSE: VRX) brodalumab posted by the U.S. FDA. They can be accessed... More
Valeant Pharma (VRX) Will Report Q2 Results on August 9th
July 15, 2016 8:05 AM EDTValeant Pharma (NYSE: VRX) announced that it plans to host a conference call and live webcast on August 9, 2016 to discuss second quarter 2016 financial results.
Conference Call... More
